| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |